Article Citation
Nashawi M, Ahmed MS, Amin T, Abualfoul M, Chilton R. Cardiovascular benefits from SGLT2 inhibition in type 2 diabetes mellitus patients is not impaired with phosphate flux related to pharmacotherapy. World J Cardiol 2021; 13(12): 676-694 [PMID: 35070111 DOI: 10.4330/wjc.v13.i12.676]
Please LOGIN to submit a new comment.